UMeWorld Establishes Product Innovation & Development Center, Appoints Chief Scientist, and Expands Global Market Reach
UMeWorld (OTC:UMEWF) has announced major strategic developments, including the establishment of a new Product Innovation & Development Center and the appointment of Dr. Zhang Guangxian as Chief Scientist. The company is preparing for the U.S. launch of its DAGola premium cooking oil products by early May, produced at a California facility.
The DAGola product line includes Gourmet, Master Chef, and Vitality Blends, featuring non-seed oils with up to 80% less triglycerides compared to conventional oils. The company is implementing a multi-channel strategy, supplying DAG oil to food manufacturers and entering the private label market.
UMeWorld is expanding internationally, targeting Japan as its next strategic market. The global healthy cooking oil market is projected to exceed $30 billion by 2030. The company's proprietary enzymatic technology focuses on addressing health issues like metabolic disorders, cardiovascular disease, and obesity through improved dietary fats.
UMeWorld (OTC:UMEWF) ha annunciato importanti sviluppi strategici, tra cui la creazione di un nuovo Centro di Innovazione e Sviluppo Prodotti e la nomina del Dr. Zhang Guangxian come Scienziato Capo. L'azienda si sta preparando per il lancio negli Stati Uniti dei suoi prodotti di olio da cucina premium DAGola entro inizio maggio, prodotti in una struttura in California.
La linea di prodotti DAGola include Gourmet, Master Chef e Vitality Blends, caratterizzati da oli non a base di semi con fino all'80% di trigliceridi in meno rispetto agli oli convenzionali. L'azienda sta implementando una strategia multi-canale, fornendo olio DAG ai produttori alimentari e entrando nel mercato delle etichette private.
UMeWorld si sta espandendo a livello internazionale, puntando al Giappone come prossimo mercato strategico. Si prevede che il mercato globale degli oli da cucina salutari supererà $30 miliardi entro il 2030. La tecnologia enzimatica proprietaria dell'azienda si concentra sulla risoluzione di problemi di salute come i disturbi metabolici, le malattie cardiovascolari e l'obesità attraverso il miglioramento dei grassi alimentari.
UMeWorld (OTC:UMEWF) ha anunciado importantes desarrollos estratégicos, incluida la creación de un nuevo Centro de Innovación y Desarrollo de Productos y el nombramiento del Dr. Zhang Guangxian como Científico Jefe. La empresa se está preparando para el lanzamiento en EE. UU. de sus productos de aceite de cocina premium DAGola a principios de mayo, producidos en una instalación en California.
La línea de productos DAGola incluye Gourmet, Master Chef y Vitality Blends, que presentan aceites no derivados de semillas con hasta un 80% menos de triglicéridos en comparación con los aceites convencionales. La empresa está implementando una estrategia multicanal, suministrando aceite DAG a fabricantes de alimentos y entrando en el mercado de marcas privadas.
UMeWorld se está expandiendo internacionalmente, apuntando a Japón como su próximo mercado estratégico. Se proyecta que el mercado global de aceites de cocina saludables superará $30 mil millones para 2030. La tecnología enzimática propietaria de la empresa se centra en abordar problemas de salud como trastornos metabólicos, enfermedades cardiovasculares y obesidad a través de grasas dietéticas mejoradas.
UMeWorld (OTC:UMEWF)는 새로운 제품 혁신 및 개발 센터 설립과 장광현 박사를 수석 과학자로 임명하는 등 주요 전략적 발전을 발표했습니다. 이 회사는 캘리포니아 시설에서 생산된 프리미엄 요리유 제품 DAGola를 5월 초에 미국 시장에 출시할 준비를 하고 있습니다.
DAGola 제품 라인은 고급, 마스터 셰프 및 비타민 블렌드를 포함하며, 기존의 기름에 비해 최대 80% 적은 트리글리세리드를 함유한 비씨앗 오일을 특징으로 합니다. 이 회사는 다채널 전략을 구현하고 있으며, DAG 오일을 식품 제조업체에 공급하고 개인 상표 시장에 진입하고 있습니다.
UMeWorld는 일본을 다음 전략적 시장으로 목표로 하여 국제적으로 확장하고 있습니다. 글로벌 건강 요리유 시장은 2030년까지 300억 달러를 초과할 것으로 예상됩니다. 회사의 독점 효소 기술은 대사 장애, 심혈관 질환 및 비만과 같은 건강 문제를 해결하는 데 중점을 두고 있습니다.
UMeWorld (OTC:UMEWF) a annoncé d'importants développements stratégiques, y compris la création d'un nouveau Centre d'Innovation et de Développement des Produits et la nomination du Dr. Zhang Guangxian en tant que Scientifique en Chef. L'entreprise se prépare au lancement aux États-Unis de ses produits d'huile de cuisson premium DAGola d'ici début mai, produits dans une installation en Californie.
La gamme de produits DAGola comprend Gourmet, Master Chef et Vitality Blends, présentant des huiles non issues de graines avec jusqu'à 80 % de triglycérides en moins par rapport aux huiles conventionnelles. L'entreprise met en œuvre une stratégie multicanale, fournissant de l'huile DAG aux fabricants alimentaires et entrant sur le marché des marques de distributeur.
UMeWorld s'étend à l'international, ciblant le Japon comme son prochain marché stratégique. Le marché mondial des huiles de cuisson saines devrait dépasser 30 milliards de dollars d'ici 2030. La technologie enzymatique propriétaire de l'entreprise se concentre sur la résolution de problèmes de santé tels que les troubles métaboliques, les maladies cardiovasculaires et l'obésité grâce à des graisses alimentaires améliorées.
UMeWorld (OTC:UMEWF) hat bedeutende strategische Entwicklungen angekündigt, darunter die Gründung eines neuen Innovations- und Entwicklungszentrums für Produkte und die Ernennung von Dr. Zhang Guangxian zum Chefwissenschaftler. Das Unternehmen bereitet sich auf die Einführung seiner Premium-Kochölprodukte DAGola in den USA bis Anfang Mai vor, die in einer Einrichtung in Kalifornien produziert werden.
Die Produktlinie DAGola umfasst Gourmet, Master Chef und Vitality Blends, die nicht aus Samen gewonnene Öle mit bis zu 80 % weniger Triglyceriden im Vergleich zu herkömmlichen Ölen enthalten. Das Unternehmen setzt eine Multi-Channel-Strategie um, indem es DAG-Öl an Lebensmittelhersteller liefert und in den Markt für Eigenmarken eintritt.
UMeWorld expandiert international und zielt darauf ab, Japan als nächsten strategischen Markt zu erschließen. Der globale Markt für gesunde Kochöle wird voraussichtlich bis 2030 über 30 Milliarden Dollar überschreiten. Die proprietäre enzymatische Technologie des Unternehmens konzentriert sich darauf, Gesundheitsprobleme wie Stoffwechselstörungen, Herz-Kreislauf-Erkrankungen und Fettleibigkeit durch verbesserte Fette in der Ernährung anzugehen.
- Appointment of experienced Chief Scientist with 20+ years in enzymatic science
- Imminent US product launch of DAGola oil products by May 2025
- Proprietary enzymatic technology with 80% less triglycerides than conventional oils
- Multi-channel revenue strategy including retail, B2B, and private label
- Expansion into Japanese market with significant growth potential
- Targeting $30 billion global healthy cooking oil market by 2030
- Entering highly competitive cooking oil market with established players
- Success dependent on consumer adoption of premium-priced cooking oil products
- Reliance on contract manufacturing facility for production
MIAMI, April 10, 2025 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC:UMEWF) is accelerating its long-term strategy to deliver science-backed, nutrition-forward consumer products with the establishment of a new Product Innovation & Development Center and the appointment of Dr. Zhang Guangxian as Chief Scientist. Dr. Zhang brings over two decades of industry experience in enzymatic science and commercial food innovation, with a strong track record of developing functional ingredients and nutrition-based solutions for large-scale production. His leadership will be instrumental in driving product development efforts that address key public health challenges through everyday foods.
The new center will focus on transforming advanced science into market-ready products, targeting major health issues such as metabolic disorders, cardiovascular disease, and obesity. By leveraging enzymatic technology, UMeWorld aims to create functional food innovations that are both highly effective and accessible to mainstream consumers.
“Our mission is simple - solve real-world health problems through better products,” said Michael Lee, CEO of UMeWorld. “With Dr. Zhang at the helm of our Product Innovation & Development Center, we’re poised to accelerate the development of next-generation nutrition solutions backed by science, not fads.”
UMeWorld is also preparing for the U.S. launch of its highly anticipated DAGola Gourmet Blend, Master Chef Blend, and Vitality Blend. Production is already underway at its contract manufacturing facility in California, and the company anticipates these premium cooking oils will be available to U.S. consumers by early May. Formulated with non-seed oils, these blends respond to growing demand for clean-label, health-focused fats.
The launch comes amid heightened consumer interest in dietary fats and their role in chronic disease. Public awareness is shifting toward the importance of fat quality in preventing metabolic disorders and improving overall health. UMeWorld’s DAGola blends are designed in line with these evolving consumer priorities, providing a healthier alternative to traditional seed-based oils.
At the core of these new products is DAGola oil, which is produced using a proprietary enzymatic process that results in up to
In addition to marketing DAGola oil under its own brand, UMeWorld is executing a multi-channel go-to-market strategy that includes supplying DAG oil to food manufacturers, especially those producing fried and processed foods such as chips, chicken, and seafood. The company is also entering the private label market, offering DAG-based oils to supermarket chains seeking functional, better-for-you pantry items for their consumers.
According to market research, the global healthy cooking oil market is projected to surpass USD 30 billion by 2030, fueled by growing awareness of the relationship between diet and chronic illness. With its proprietary enzymatic technology and unique triglyceride-reducing formulation, UMeWorld is well-positioned to lead in this rapidly expanding category.
“DAGola isn’t just another better-for-you oil - it’s structurally different,” added Lee. “Our proprietary enzymatic technology gives us a distinct competitive advantage in health impact, taste, and scientific credibility. We’re not just making claims - we’re building real solutions.”
UMeWorld has also identified Japan as its next strategic growth market. With an aging population and high demand for functional, health-enhancing foods, Japan represents an ideal opportunity for DAGola’s science-driven offerings. The company is currently engaging with potential distribution and retail partners in the region.
Looking ahead, UMeWorld will continue to expand its product pipeline, deepen its strategic partnerships, and grow its international presence. Amid global economic uncertainty and rising healthcare costs, the company sees strong momentum for affordable, accessible innovations that empower consumers to take control of their health through smarter food choices.
About UMeWorld
At UMeWorld, we merge innovation with science to revolutionize the cooking oil industry. DAGola™ oil is a science-backed alternative with up to
About DAGola Inc.
DAGola Inc. is the U.S. branch of UMeWorld Limited. It focuses on selling innovative food products in North America. To learn more about DAGola Inc., visit www.dagolaoil.com and amazon.com/dagola.
Forward-Looking Statements
This press release may contain forward-looking statements, about UMeWorld's expectations, beliefs or intentions regarding, among other things, its product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time to time, UMeWorld or its representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be identified by the use of forward-looking words such as "believe," "expect," "intend," "plan," "may," "should" or "anticipate" or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by UMeWorld with the U.S. Securities and Exchange Commission, press releases or oral statements made by or with the approval of one of UMeWorld's authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause UMeWorld's actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause UMeWorld's actual activities or results to differ materially from the activities and results anticipated in such forward-looking statements, including, but not limited to, the factors summarized in UMeWorld's filings with the SEC. In addition, UMeWorld operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond its control. UMeWorld does not undertake any obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise. Please see the risk factors associated with an investment in our securities which are included in our Annual Report on Form 20-F and other periodic and current reports filed with the Securities and Exchange Commission.
Contact: Michael Lee UMeWorld Limited Email: info@umeworld.com
FAQ
When will UMeWorld (UMEWF) launch its DAGola cooking oil products in the US market?
What are the key health benefits of UMeWorld's (UMEWF) DAGola oil products?
What is UMeWorld's (UMEWF) market strategy for DAGola oil distribution?
What is the growth potential for UMeWorld's (UMEWF) healthy cooking oil market?
Which international market is UMeWorld (UMEWF) targeting for expansion?
